Evidence map›Paper›PMID 30188929›Full record

ArticlePloS one2018

Metabolic syndrome in Xinjiang Kazakhs and construction of a risk prediction model for cardiovascular disease risk.

Lei Mao, Jia He, Xiang Gao, Heng Guo, Kui Wang, Xianghui Zhang, Wenwen Yang, Jingyu Zhang, Shugang Li, Yunhua Hu and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 1 institution in 2 countries.

Lei MaoDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Jia HeDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Xiang GaoDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Heng GuoDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Kui WangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Xianghui ZhangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Wenwen YangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Jingyu ZhangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Shugang LiDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Yunhua HuDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Lati MuDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Yizhong YanDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Jiaolong MaDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Yusong DingDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Mei ZhangDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Jiaming LiuDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Rulin MaDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.
Shuxia GuoDepartment of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China.ORCID 0000-0002-8139-2813
Shihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high prevalence of metabolic syndrome (MetS) and cardiovascular diseases (CVD) is observed among Kazakhs in Xinjiang. Because MetS may significantly predict the occurrence of CVD, the inclusion of CVD-related indicators in metabolic network may improve the predictive ability for a CVD-risk model for Kazakhs in Xinjiang.

methodsThe study included 2,644 subjects who were followed for 5 years or longer. CVD cases were identified via medical records of the local hospitals from April 2016 to August 2017. Factor analysis was performed in 706 subjects (267 men and 439 women) with MetS to extract CVD-related potential factors from 18 biomarkers tested in a routine health check-up, served as a synthetic predictor (SP). We evaluated the predictive ability of the CVD-risk model using age and SP, logistic regression discrimination for internal validation (n = 384; men = 164, women = 220) and external validation (n = 219; men = 89, women = 130), calculated the probability of CVD for each participant, and receiver operating characteristic curves.

resultsAccording to the diagnostic criteria of JIS, the prevalence of MetS in Kazakh was 30.9%. Seven potential factors with a similar pattern were obtained from men and women and comprised the CVD predictors. When predicting CVD in the internal validation, the area under the curve (AUC) were 0.857 (95%CI 0.807-0.898) for men and 0.852 (95%CI 0.809-0.889) for women, respectively. In the external validation, the AUC to predict CVD were 0.914 (95%CI 0.832-0.963) for men and 0.848 (95%CI 0.774-0.905) for women. It is suggested that SP might serve as a useful tool in identifying CVD with in Kazakhs, especially for Kazakhs men.

conclusionsAmong 7 potential factors were extracted from 18 biomarkrs in Kazakhs with MetS, and SP may be used for CVD risk assessment.

Indexed as

AdultArea Under CurveCardiovascular DiseasesChinaFemaleHumansMaleMetabolic SyndromeMiddle AgedRisk FactorsROC Curve

Identifiers

PMID30188929
PMCPMC6126809
OpenAlexW2891965092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.